TABLE 2.
Monitoring objectives | Number of national monitoring systems (out of 15) |
A. Monitoring AMR trends in animal bacterial pathogens to antimicrobials of interest for veterinary medicine | 14 |
B. Detecting AMR emergences in animal bacterial pathogens to antimicrobials of interest for veterinary medicine | 13 |
C. Monitoring AMR trends in animal bacterial pathogens to antimicrobials of interest for public health* | 12 |
D. Detecting AMR emergences in animal bacterial pathogens to antimicrobials of interest for public health* | 12 |
E. Informing veterinarians on AMR levels in animal bacterial pathogens, to help them in their antimicrobial treatment decisions | 13 |
F. Developing antimicrobial therapy guidelines intended to veterinarians | 6 |
G. Monitoring the impact of the National Action Plan (along with other possible indicators such as antimicrobial use data) | 5 |
H. Advising policy makers on interventions to mitigate AMR | 7 |
I. Better understanding the AMR epidemiological links between the animal and human sectors | 6 |
J. Better understanding the AMR epidemiological links between the animal and environmental sectors | 3 |
K. Better understanding the links between AMR and antimicrobial use data | 8 |
L. Assessing the risk of AMR transmission between animals and humans via non-food related routes (e.g., by direct contact between humans and companion or food-producing animals) | 7 |
M. Estimating the burden of AMR in animal health (e.g., attributable deaths and morbidity caused by infections with antimicrobial-resistant bacteria in animals) | 0 |
N. Other monitoring objective | 0 |
*Many antimicrobials are of interest to both animal and public health. This objective was ticked only if the monitoring system does aim to provide useful AMR data in a public health perspective.